Celerato is a Swiss MedTech startup that advances structured reporting in the field of pathology and cytopathology. We offer an efficient all-in-one solution for creating structured reports, consisting of a comprehensive and intuitive software, as well as a large selection of intelligent forms. Celerato AG, is a MedTech startup providing structured medical reporting to improve patient care and medical outcome. Celerato offers the digital reporting assistant SynReport for local installation (on-premises), including a web platform (SynReport-Platform) for collaborative development of structured forms. In addition, Celerato provides validated structured reporting forms for pathology, cytopathology, and molecular pathology. The tool enables continuous data integration by providing interfaces to connect with other data systems, enabling continuous integration of AI tools.

Celerato was founded to improve and automate reporting in medicine.

SynReport was developed as a part of the PathoLink research project at the University of Zurich in collaboration with five university hospitals in Switzerland. The main goal of PathoLink was to create sharable datasets to facilitate diagnostics and research. The development of SynReport software started in 2017 and since 2019 it has been used in routine diagnostics. To continue the development, a startup was founded in 2020. Today, Celerato has five employees and is continuously expanding its user and customer base. Celerato is in contact with ICCR-Cancer and pathological societies in individual countries to improve synoptic structured medical reporting.